Paratek caps 20-year R&D journey with FDA OK for its broad spectrum antibiotic — time to talk launch
Paratek has bagged its first — and second — FDA OK for its antibiotics on the same day.
The big approval, 20 years in the making, goes …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
